CRISM Therapeutics Corporation
CRTX.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -£1 | -£2 | -£2 | -£1 |
| Dep. & Amort. | £0 | £0 | £0 | £0 |
| Deferred Tax | £0 | £0 | £0 | £0 |
| Stock-Based Comp. | £0 | £0 | £0 | £0 |
| Change in WC | -£0 | £0 | £0 | £0 |
| Other Non-Cash | -£0 | -£1 | -£1 | -£1 |
| Operating Cash Flow | -£1 | -£3 | -£3 | -£1 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -£0 | £0 | -£0 | -£0 |
| Net Acquisitions | £2 | £0 | £0 | £0 |
| Inv. Purchases | £0 | £0 | £0 | £0 |
| Inv. Sales/Matur. | £0 | £0 | £0 | £4 |
| Other Inv. Act. | £0 | £35 | -£0 | £2 |
| Investing Cash Flow | £2 | £35 | -£1 | £6 |
| Financing Activities | – | – | – | – |
| Debt Repay. | £0 | £0 | £0 | £0 |
| Stock Issued | £0 | £0 | £0 | £0 |
| Stock Repurch. | £0 | £0 | £0 | £0 |
| Dividends Paid | -£0 | -£31 | £0 | £0 |
| Other Fin. Act. | -£0 | £0 | £1 | £0 |
| Financing Cash Flow | -£0 | -£31 | £1 | £0 |
| Forex Effect | -£0 | £0 | £0 | -£0 |
| Net Chg. in Cash | £1 | £1 | -£3 | £4 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | £0 | £4 | £5 | £2 |
| End Cash | £1 | £4 | £3 | £5 |
| Free Cash Flow | -£1 | -£3 | -£3 | -£1 |